Oncology

  1. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by Sanofi
    for Skin Cancer
    €17,380.00
  2. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €8,382.72
  3. Vitrakvi (larotrectinib)
    Vitrakvi (larotrectinib)
    by Bayer
    for Solid Tumor
    €14,800.00
  4. Vizimpro (dacomitinib)
    Vizimpro (dacomitinib)
    by Pfizer Limited
    for Lung Cancer
    €19,680.00
  5. Copiktra (duvelisib)
    Copiktra (duvelisib)
    by Verastem Inc.
    for Leukemia, Lymphoma
    €16,800.00
  6. Erleada (apalutamide)
    Erleada (apalutamide)
    by Janssen Biotech
    for Prostate Cancer
    €4,225.86
  7. Nerlynx (neratinib)
    Nerlynx (neratinib)
    by Puma biotechnology
    for Breast Cancer
    €17,800.00
  8. Truxima (rituximab)
    Truxima (rituximab)
    by Teva Pharmaceuticals, Celltrion Healthcare Hungary Kft
    for Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis , Polyangiitis
    €852.00
  9. Aliqopa (copanlisib)
    Aliqopa (copanlisib)
    by Bayer
    for Lymphoma
    €7,915.32
View as Grid List

Items 1-9 of 39

Page
per page
Set Descending Direction